|
AU2013205465A1
|
|
Method for replicating influenza virus in culture
|
|
US2009170954A1
|
|
Process for Recovering Florfenicol and Florfenicol Analogs
|
|
CA2702800A1
|
|
Long acting injectable formulations
|
|
TW200924647A
|
|
Local topical administration formulations containing fipronil
|
|
KR20100022999A
|
|
A process for preparing oxazoline-protected aminodiol compounds useful as intermediates to florfenicol
|
|
CN101686956A
|
|
Compounds and methods for enhancing solubility of florfenicol and structurally-related antibiotics using cyclodextrins
|
|
MX2009006893A
|
|
Pharmaceutical compositions and method for treating inflammation in cattle and other animals.
|
|
CA2672863A1
|
|
Effervescent formulations of florfenicol for addition in drinking water systems
|
|
UA100849C2
|
|
Normal;heading 1;heading 2;heading 3;METHOD FOR REPLICATING INFLUENZA VIRUS IN CULTURE
|
|
BRPI0720304A2
|
|
Method to reply influentive virus in culture
|
|
MX2009006468A
|
|
Water-soluble phenicol prodrugs in a lipophilic vehicle system.
|
|
NZ578352A
|
|
Canine thymic stromal lymphopoietin protein and uses thereof
|
|
CN101600686A
|
|
The water-soluble prodrug of paraxin, thiamphenicol and analogue thereof
|
|
MX2009006282A
|
|
Water-soluble prodrugs of florfenicol and its analogs.
|
|
MX2009004866A
|
|
Canine lyme disease vaccine.
|
|
CA2660360A1
|
|
Methods and systems for storing and providing information related to companion animals
|
|
AU2007203386A1
|
|
Methods for the in vitro culture of sporozoea SP. and user thereof
|
|
ZA200705170B
|
|
Neutralizing epitope-based growth enhancing vaccine
|
|
UA95951C2
|
|
Recombinant attenuated clostridium organisms
|
|
EP2004595A1
|
|
N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
|
